Over the current book year the company from Indianapolis could achieve a revenue around 27.99 billion USD (consensus estimates). This is hugely more than 2020's revenue of 24.54 billion USD.
The analysts expect for 2021 a net profit of 7.61 billion USD. For this year the consensus of the result per share is a profit of 8.36 USD. The price-earnings-ratio equals 24.51.
Per share the analysts are expecting a dividend of 3.37 USD per share. Eli Lilly's dividend yield thus equals 1.64 percent. The average dividend yield of the pharmaceutical companies is a limited 0.38 percent.
Eli Lilly's market capitalization is based on the number of outstanding shares around 196.19 billion USD. The Eli Lilly stock was the past 12 months quite volatile. Since last February the stock is even 66 percent higher. This year the stock price moved between 117 and 218 dollar.
Click here for dividend Eli Lilly. On Friday the stock closed at 204.89 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.